Answers are grounded in this paper and cite their sources.
Objectives [1] To determine first choice of steroid administered to children with viral wheeze and acute asthma [2] To compare tolerability of Prednisolone tablets vs Dexamethasone suspension Methods We reviewed the medical records of 119 children seen in the emergency department, with acute asthma or viral wheeze between April and June 2023. Data was collected about the type of steroid first administered and incidences of vomiting after the first steroid administration based on age groups. Results A total of 86/119 children were given oral corticosteroid, 62 were below 5 years of age and 24 were over 5 years of age. Only 2 children were less than 1 year of age, and neither of them received steroids. 73/86 (84.9%) children received crushed Prednisolone tablets as first choice whilst 13/86 (15.1%) children received Dexamethasone suspension of which 11 of these were ≤ 5 years and 2 of them were over 5 years (figure 1). Vomiting was mostly seen in very young children, as majority 6/8 (75%) of them were below 2 years and all children who vomited were younger than 5 years of age. 7/73 (9.6%) children vomited Prednisolone and only 1/13 (7.7%) vomited Dexamethasone (figure 2). Conclusion Majority of children were given crushed Prednisolone tablets as the first steroid of choice in management of acute asthma or viral wheeze, this is the cost-effective Prednisolone formulation available in the Trust and recommended in our current guidelines.¹ A single dose of 0.3mg/kg Dexamethasone is as effective as 3–5 day course of Prednisolone as per previous studies² ³ and is included in the local guideline. Dexamethasone is recommended as second line treatment in children who vomit Prednisolone⁴ as a cost-effective option, compared to other Prednisolone formulations,⁵ it is however more potent and has a higher risk of systemic side effects.⁶ Dexamethasone suspension was mostly preferred by nursing staff for children below 5 years age as vomiting after oral steroid administration was often anticipated in younger children. Prednisolone tablets were well tolerated in most of the patients and the few who vomited were below 5 years age. This study gives further evidence for use of oral Prednisolone in the first instance, in management of children with acute asthma and viral wheeze when steroids are indicated. Since our data highlights vomiting to be common in younger children, we propose that a more palatable Prednisolone preparation should be considered for children under 2 years of age. References SIGN 158 British Thoracic Society, Guidelines on Management of asthma, July 2019. Archives of Diseases of Childhood, British Respiratory Society Rachel McGalliard, Sarah Humphreys, Laura Lisboa, Lakshmi Chilukuri, 2022. Archives of Diseases in Childhood, Susan Wallace, Nigel IJ Chan, Heidi Makrinioti, Bob Phillips; May 2021. Creasey N. Archives of Diseases in Childhood, April 2016. National Health Service Electronic Drug Tariff, September 2023. Dennis M Williams, Respiratory Care, June 2018.
No takes yet. Share an insight, caveat, or question.
Akintade et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: